E-cadherin expression in upper urothelial carcinoma in Balkan Endemic Nephropathy and non-endemic regions

Pathology Research and Practice

Volumn 205, Issue 10, 2009, Pages 682-689

  Velickovic, Ljubinka Jankovic ^a   Hattori, Takanori ^b   Visnjic, Milan ^a   Dimov, Irena ^a   Stojanovic, Mariola ^c   Stefanovic, Vladisav ^a  

^a Faculty of Medicine   (Serbia)

^b SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^c Public Health Institute   (Serbia)

Author keywords

Balkan Endemic Nephropathy; E cadherin; Morphological variables; Upper urothelial carcinoma

Indexed keywords

EOSIN; HEMATOXYLIN; MONOCLONAL ANTIBODY; UVOMORULIN;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER INCIDENCE; CANCER STAGING; CONTROLLED STUDY; CYTOPLASM; DISEASE COURSE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INTERSTITIAL NEPHRITIS; MAJOR CLINICAL STUDY; MALE; MORPHOLOGY; NEPHROURETERECTOMY; PROTEIN EXPRESSION; TUMOR GROWTH; URBAN RURAL DIFFERENCE; UROGENITAL TRACT CANCER;

ADULT; AGED; AGED, 80 AND OVER; BALKAN NEPHROPATHY; CADHERINS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM STAGING; SERBIA; UROLOGIC NEOPLASMS; UROTHELIUM;

EID: 70349134345     PISSN: 03440338     EISSN: 16180631     Source Type: Journal    
DOI: 10.1016/j.prp.2009.03.007     Document Type: Article

References (34)

1. Bukvic D., Jankovic S., and Djukanovic Lj. Urinary tract tumors in Kolubara region. Facta Universitatis 11 (2004) 5-10
2. Cai T., Piazzini M., Nesi G., Taddei I., Sardi I., Detti B., Mondani N., Dal Conto M., and Bartoletti R. E-cadherin mRNA expression analysis in evaluating the natural history of urothelial bladder cell carcinoma: results from a long-term follow-up study. Oncol. Rep. 17 (2007) 925-930
3. Campbell R.J., and Pignatelli M. Molecular histology in the study of solid tumours. Mol. Pathol. 55 (2002) 80-82
4. Charalabopoulos K., Tsambals S., Syrigos K., Giannakopoulos X., Kalfakakou V., Kiortsis D., Alamanos J., et al. Correlation of E-cadherin expression with clinicopathological data in patients suffering from transitional cell carcinoma of the bladder. Exp. Oncol. 25 (2003) 180-185
5. Chetty R., and Serra S. Membrane loss and aberrant nuclear localization of E-cadherin are consistent features of solid pseudopapillary tumor of the pancreas. An immunohistochemical study using two antibodies recognizing different domains of the E-cadherin molecule. Histopathology 52 (2008) 325-330
6. Clairotte A., Lascombe I., Fauconnet S., Mauny F., Felix S., Algros M.P., Bittard H., and Kantelip B. Expression of E-cadherin and alpha-, beta-, gamma-catenins in patients with bladder cancer: identification of gamma-catenin as a new prognostic marker of neoplastic progression in T1 superficial urothelial tumors. Am. J. Clin. Pathol. 125 (2006) 119-126
7. Da Silva L., Parry S., Reid L., Keith P., Waddell N., Kossai M., Clarke C., et al. Aberrant expression of E-cadherin in lobular carcinomas of the breast. Am. J. Surg. Pathol. 32 (2008) 773-783
8. Eltz S., Comperat E., Cussenot O., and Roupret M. Molecular and histological markers in urothelial carcinomas of the upper urinary tract. Br. J. Urol. Int. 102 (2008) 532-535
9. Fromont G., Roupret M., Amira N., Sibony M., Vallancien G., Validire P., and Cussenot O. Tissue microarray analysis of the prognostic value of E-cadherin, Ki-67, p53, p27, survivin and MSH2 expression in upper urinary tract transitional cell carcinoma. Eur. Urol. 48 (2005) 764-770
10. Fujisawa M., Miyazaki J., Takechi Y., Arakawa S., and Kamidono S. The significance of E-cadherin in transitional-cell carcinoma of the human urinary bladder. World J. Urol. 14 (1996) S12-S15
11. Genega E.M., Kapali M., Torres-Quinones M., Huang W.C., Knauss J.S., Wang L.P., Raghunath P.N., Kozlowski C., Malkowicz S.B., and Tomaszewski J.E. Impact of the 1998 World Health Organization/International Society of Urological Pathology classification system for urothelial neoplasms of the kidney. Mod. Pathol. 18 (2005) 11-18
12. Genega M.E., and Porter R.C. Urothelial neoplasms of the kidney and ureter. Am. J. Clin. Pathol. 117 (2002) S36-S48
13. Horikawa Y., Sugano K., Shigyo M., et al. Hypermethylation of an E-cadherin (CDH-1) promoter region in high grade transitional cell carcinoma of the bladder comprising carcinoma in situ. J. Urol. 169 (2003) 1541-1545
14. Jimenez R.E., Gheiler E., Oskanian P., Tignert R., Sakr W., Wood Jr. D.P., Poutes J.E., and Grignon D.J. The invasive component of urothelial carcinoma of the bladder and its relationship with progression - free survival. Am. J. Surg. Pathol. 24 (2000) 980-987
15. Jung I., and Messing E. Molecular mechanisms and pathways in bladder cancer development and progression. Cancer Control 7 (2000) 325-334
16. Kashibuchi K., Tomita K., Schalken J.A., Kume H., Yamaguchi T., Muto S., Horie S., and Kitamura T. The prognostic value of E-cadherin, alpha-, beta-, and gamma-catenin in urothelial cancer of the upper urinary tract. Eur. Urol. 49 (2005) 839-845
17. Koksal I.T., Ates M., Danisman A., Sezer C., Ciftcioglu A., Karpuzoglu G., and Sevuk M. Reduced E-cadherin and α-catenin expressions have no prognostic role in bladder carcinoma. Pathol. Oncol. Res. 12 (2006) 13-19
18. Lascombe I., Clairotte A., Fauconnet S., Bernardini S., Wallerand H., Kantelip B., and Bittard H. N-cadherin as a novel prognostic marker of progression in superficial urothelial tumors. Clin. Cancer Res. 12 (2006) 2780-2787
19. Leder R.A., and Dunnick N.R. Transitional cell carcinoma of the pelvicalices and ureter. Am. J. Roentgenol. 155 (1990) 713-722
20. Lipponen P.K., and Eskelinen M.J. Reduced expression of E-cadherin is related to invasive disease and frequent recurrence in bladder cancer. J. Cancer Res. Clin. Oncol. 121 (1995) 303-308
21. Lopez-Beltran A., Sauter G., Gasser T., Hartmann A., Schmitz-Drager B.J., Helpap B., Ayala A.G., Tamboli P., Knowles M.A., Sidransky D., Cordon-Cardo C., Jones P.A., Cairns P., Simon R., Amin M.B., and Tyezinski J.E. Tumors of the urinary system. Infiltrating urothelial carcinoma. In: Eble J.N., Sauter G., Epstein J.I., and Sesterhenn I.A. (Eds). World Health Organization Classification of Tumours. Pathology and Genetics. Tumours of the Urinary System and Male Genital Organs (2004), IARC, Lyon 93-109
22. Mihatsch M.J., and Knusli C. Phenacetin abuse and malignant tumors. An autopsy study covering 25 years (1953-1977). Klin. Wochenschr. 60 (1982) 1339-1349
23. Nakanishi K., Kawai T., Torikata C., Aureus T., and Ikeda T. E-cadherin expression in upper-urinary-tract carcinoma. Int. J. Cancer 74 (1997) 446-449
24. Oliveira P.A., Colaco A., De la Cruz L.F., Lopes P., and Lopes C. E-cadherin expression during urothelial carcinogenesis induced by N-butyl-N-(4-hydroxybutyl) nitrosamine in rats. J. Exp. Clin. Cancer Res. 25 (2006) 425-432
25. Pecina-Straus N. Tumor suppressor gene E-cadherin and its role in normal and malignant cells. Cancer Cell Intern. 3 (2003) 1-7
26. Popov Z., Gil-Diez de Medina S., Lefrere-Belda M.-A., Hoznek A., Bastuji-Garin S., Abbou C.C., and Thiery J.P. Low E-cadherin expression in bladder cancer at the transcriptional and protein level provides prognostic information. Br. J. Cancer 83 (2000) 209-214
27. Rieger-Christ K.M., Cain J.W., Braasch J.W., Dugan J.M., Silverman M.L., Bouyounes B., Libertino J.A., and Summerhayes I.C. Expression of classic cadherins type I in urothelial neoplastic progression. Hum. Pathol. 32 (2001) 18-23
28. Ross J.S., and Cohen M.B. Biomarkers for the detection of bladder cancer. Adv. Anat. Pathol. 8 (2001) 37-45
29. San Miguel Fraile P., Gomez de Maria C., Donis Quintairos L., Carrera Vazquez A., Inlesias Martinez P., and Barreiro Barbosa M.J. E-cadherin and catenins expression in urothelial carcinoma. Actas Urol. Esp. 31 (2007) 355-360
30. Serra S., Salahshor S., Fagih M., Niakosari F., Radhi J.M., and Chetty R. Nuclear expression of E-cadherin in solid pseudopapillary tumors of the pancreas. JOP 8 (2007) 296-303
31. In: Sobin L.H., and Wittekind C. (Eds). TNM Classification of Malignant Tumors. sixth ed (2002), Wiley-Liss, New York
32. Stefanovic V., and Radovanovic Z. Balkan endemic nephropathy and associated urothelial cancer. Nat. Clin. Pract. Urol. 5 (2008) 105-112
33. Sun W., and Herrera G. E-cadherin expression in invasive urothelial carcinoma. Ann. Diagn. Pathol. 8 (2004) 17-22
34. Szekely E., Torok V., Szekely T., Riesz P., and Romics I. E-cadherin expression in transitional cell carcinomas. Pathol. Oncol. Res. 12 (2006) 73-77